LOINC display name : Adrenal cancer risk assessment and urine steroid fractions panel;
LOINC long common name : Adrenal cancer risk assessment and urine steroid fractions panel;
LOINC short name : Adrenal ca risk assess ur steroid Pnl;
LOINC description : A risk assessment based on patient clinical data combined with biochemical steroid
results to assess the probability of a malignant adrenal cortical carcinoma (ACC)
or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass
(e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis,
gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter,
and density of the tumor by CT.;
Has component